Efinaconazole

Generic Name
Efinaconazole
Brand Names
Jublia
Drug Type
Small Molecule
Chemical Formula
C18H22F2N4O
CAS Number
164650-44-6
Unique Ingredient Identifier
J82SB7FXWB
Background

Efinaconazole is a 14 alpha-demethylase inhibitor indicated in the treatment of fungal infection of the nail, known as onychomycosis. It was approved for use in Canada and the USA in 2014 and is marketed by Valeant Pharmaceuticals North America LLC under the name Jublia.

Indication

Indicated in the treatment of fungal infection of the nail, known as onychomycosis.

Associated Conditions
Onychomycosis
Associated Therapies
-
© Copyright 2024. All Rights Reserved by MedPath